We need your help! Please encourage your Senators to cosponsor the BENEFIT Act.
This legislation will amend the Food, Drug and Cosmetic Act (FDCA) to ensure that patient experience, PFDD and related data – including information developed by a product sponsor or a third party such as a patient advocacy organization or academic institution – be considered as part of the risk-benefit assessment.
This action will send an important signal to all stakeholders that patient experience and PFDD data will be fully incorporated into the agency’s review process and will encourage such entities to develop scientifically rigorous and meaningful tools and data.
Thank you for advocating! Please take one minute and fill out this form to be sent directly to your two US Senators and one House member.Take Action >